Clarify Journeys

What are the diagnosis, treatment, and outcome patterns of my patient cohorts?

Clarify Segments

How can I maximize my brand’s performance within each HCP segment?

Clarify Access

How can I optimize my payer marketing strategy to accelerate market access?

Clarify Trials

Clarify Trials

Which sites and investigators have the best opportunity to recruit diverse patients into my clinical trial?

Pharma commercial teams see real ROI

60%

More patients with a rare heart condition were identified by uncovering patients who were most likely mis-diagnosed

3x

More scripts of a rare disease treatment were written by HCPs that Clarify scored as high-opportunity

7k

Patients identified at high risk of non-adherence to infusion therapy by using social determinants of health data

Life sciences analytics, queryable in seconds

Clarify Health Clarify Journeys

Clarify Journeys

Enhance your brand’s performance throughout its lifecycle with this RWE software. We put commercial insights in your hands instantly. The intuitive, self-service interface lets you interrogate the platform’s 300M+ SDoH-decorated, payer-complete longitudinal patient journeys to refine patient cohorts and HCP targeting and puts RWE directly into your CRM.

Clarify Segments

Whether you are assessing the potential of a partnership deal or exploring a new market opportunity, this pharma analytics software gives you the inputs you need to gauge true value, in seconds. Using its self-service capabilities, you can build precise patient cohorts, slice and dice them by clinical and non-clinical characteristics, and understand treating HCPs.

Clarify Health Clarify Segments
Clarify Health Clarify Trials

Clarify Access

Optimizing market access depends on in-depth payer insights. Acclaimed by Frost & Sullivan as life sciences’ most innovative RWE solution, this cloud software delivers on-demand payer insights to enable instant exploration of market dynamics and demonstration of therapeutic value to strengthen market access strategies. Learn about our complete Growth Suite of products for pharma commercial teams.

Clarify Trials

Real-world, social determinants of health (SDoH) insights can go a long way to making diversity in clinical trials a reality. Our RWE software delivers 400+ social determinants of health (SDoH) insights across >80% of the US population to help you select the sites and investigators that have the best opportunity to recruit diverse patients.

Clarify Health Clarify Trials

Pfizer and Clarify talk data strategies for commercialization

Pfizer and Clarify Health sat down with HLTH to talk about creating data-driven value stories for new therapies. Hear what Bhash Parasuraman, Vice President and BU Lead, Rare Disease Patient & Health Impact, Pfizer and Manisha Gulati, of Clarify Health, have to say.

Real-world evidence for pharma

Case Study

QED Therapeutics accelerates launch of rare cancer drug with analytics-driven insights into its niche market

For Life Sciences

Research

Pfizer and Clarify published a real-world study on medication adherence for rare disease patients taking tafamidis

For Life Sciences

Research

Pfizer partnered with Clarify to assess differences in real-world medication adherence between Medicaid and commercial populations taking somatropin

For Life Sciences

Blog

Merck, Bristol-Myers Squibb, and Clarify discuss diversity in clinical trials

For Life Sciences

Research

Pfizer leverages Clarify’s RWE to publish a study on diagnostic testing patterns for rare disease patients

For Life Sciences

Blog

Pfizer, Novo Nordisk, Karius, and FibroGen discuss novel use cases for precision analytics

For Life Sciences

Let’s work together